In addition, ANLN expression can also be reinforced by the RhoA/YAP1/TEAD1 feed-forward loop, indicating a promising strategy for ICC treatment by targeting this signaling axis (Fig. 9). The gene discussed is TEAD1; the disease is intrahepatic cholangiocarcinoma.